Combined Therapies with Taxane-Based Chemotherapeutic Drugs in Prostate Cancer: Novel Insights and Future Directions
Oncologic disease is a significant global health issue that causes thousands of deaths annually, and it has a significant impact on the quality of life of patients. Prostate cancer (PCa) is the second most diagnosed cancer and the fourth leading cause of cancer-related death in men in the Western wo...
Main Authors: | Rafaella S. Coelho, Sandra M. Rocha, Cláudio J. Maia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | BioChem |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-6411/3/3/9 |
Similar Items
-
Impact of taxane-based chemotherapeutics on male reproductive function
by: Charvi Kanodia, et al.
Published: (2023-04-01) -
Sex Differences in Taxane Toxicities
by: Nicole N. Chmielewski, et al.
Published: (2022-07-01) -
Supplemental Preparations in Taxane-Induced Neuropathy Management
by: AmirHosein Sanei, et al.
Published: (2023-04-01) -
Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
by: Shirin Kianersi, et al.
Published: (2023-01-01) -
Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study
by: R. Dixon Dorand, et al.
Published: (2023-01-01)